ChiCTR2500113083
尚未开始
/
/
/
2025-11-24
/
/
Patients with advanced disease with a need for end-of-life care
An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
The study aims to examine the feasibility and acceptability of an evidence-based ACP programme among patients with advanced diseases in the Emergency Department. The objectives of the study are to determine the feasibility of conducting an ACP programme in the ED based on recruitment and attrition rate, to examine the acceptability of the intervention based on satisfaction survey and qualitative comments on patient’s experiences, and to examine the preliminary effect of the programme on patient reported ACP readiness and evidence of ACP documentation on medical record.
随机平行对照
其它
Eligible and consented patients will be randomised into intervention or control group in a 1:1 ratio using the Random Sequence Generator (Prachanukool et al., 2022).
Due to the nature of the intervention, the participants cannot be blinded to the group allocation. The outcome assessors will be blinded to the group allocation.
None
/
30
/
2025-11-24
2026-10-25
/
Subjects will be recruited from Emergency Medicine Wards, ED of two public hospitals in Kowloon West Cluster, Hong Kong. One of the ED is in Kwai Tsing District providing tertiary care while the other ED is located on Lantau Island providing tertiary and rehabilitation service.Participants are adult (18 years old or above) admitted to the EMW, Chinese-speaking, fulfill the two general and one clinical criterion stipulated in the Supportive and Palliative Care Indicator Tools (SPICT™) (The University of Edinburgh, 2025). SPICT was developed as an instrument to identify patients at risk of dying within one year (Paulik et al., 2024). It has a sensitivity of 0.65 (95% CI) and a specificity of 0.72 (95% CI) in detecting life-limiting conditions (Paulik et al., 2024).By using this dual indicators approach, it allows a more comprehensive and personalized model of care for patients with advanced illnesses (Paulik et al., 2024).；
请登录查看Patients will be excluded if they are mentally incompetent determined based on the Diagnostic assessment Confusion Assessment Method (3D-CAM) (Marcantonio et al., 2015). The Chinese version of 3D-CAM can be used as a reliable and accurate instrument for delirium assessment, its sensitivity ranges from 85.7 to 100% and the specificity from 95.7 to 96.4% (Mu et al., 2020). Patients who were non-Chinese speaking, non-communicable, refusal or unable to give consent, altered sensorium or cognitive functions, physical unwell to receive the intervention, and with previous documented ACP or AMD will be excluded from the study.；
请登录查看The Nethersole School of Nursing, The Chinese University of Hong Kong
/
皮肤好医荟2025-12-04
体外诊断原料网2025-12-04
优赛生命2025-12-04
医药时间2025-12-04
佰傲谷BioValley2025-12-04
求实药社2025-12-04
启迪之星2025-12-04
亚虹医药2025-12-04
幂方健康基金2025-12-04
汉氏联合2025-12-04
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
